Stanford Multidisiplinary Cutaneous Lymphoma Clinic
Excellence in Patient Care and Research
The Stanford Multidisciplinary Cutaneous Lymphoma Clinic (CLC) is a leading center of excellence for managing patients with cutaneous lymphomas (a sub-group of non-Hodgkin's lymphomas); it also serves as a regional, national, and international referral center. The majority of patients have mycosis fungoides, the most common type of cutaneous lymphoma. The CLC also evaluates and manages patients with other cutaneous lymphomas (B-cell lymphomas, CD30+ lymphomas, NK/T--cell lymphomas, panniculitis-like T-cell lymphomas, and other peripheral T-cell lymphomas). The clinic has been operating for over 30 years at Stanford with greater than 1000 patients seen.
The CLC is a multidisciplinary clinic and is co-attended by physicians from the departments of Dermatology, Radiation Oncology, Medical Oncology, and Dermatopathology. Clinicians have access to state-of-the art histochemical and molecular tools for diagnosis and patient management. The clinic offers standard therapies and participation in investigative protocols, and provides patients with up-to-date information on cutaneous lymphomas and the treatment alternatives.
Investigative treatment protocols are listed under Clinical Trials.
An integral part of our active research is long-term outcome of our patients.The CLC has an on-going cutaneous lymphoma database dating back to the 1950's with long-term follow-up period of greater than 50 years on patients. Our mycosis fungoides database contains information about more than 700 patients. We also have a separate database for cutaneous B-cell lymphoma, CD30 lymphoproliferative diseases and other cutaneous lymphomas. The databases, which are accessible only to authorized staff members, are centrally housed in the departments of Radiation Oncology and Dermatology and are updated by Dermatology staff.